Executive summary of the KDIGO 2024 Clinical Practice Guideline for the evaluation and management of chronic kidney disease: Known knowns and known unknowns

Levin, Adeera; Ahmed, Sofia B; Carrero, Juan Jesus; Foster, Bethany; Francis, Anna; Hall, Rasheeda K; Herrington, Will G; Hill, Guy; Inker, Lesley A; Kazancıoğlu, Rümeyza; Lamb, Edmund; Lin, Peter; Madero, Magdalena; McIntyre, Natasha; Morrow, Kelly; Roberts, Glenda; Sabanayagam, Dharshana; Schaeffner, Elke; Shlipak, Michael; Shroff, Rukshana; Tangri, Navdeep; Thanachayanont, Teerawat; Ulasi, Ifeoma; Wong, Germaine; Yang, Chih-Wei; Zhang, Luxia; Robinson, Karen A; Wilson, Lisa; Wilson, Renee F; Kasiske, Bertram L; Cheung, Michael; Earley, Amy; Stevens, Paul E.

Kidney int; 105 (4), 2024

Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) updates the KDIGO 2012 guideline and has been developed with patient partners, clinicians, and researchers around the world, using robust methodology. This update, based on a su...

Insuficiencia Renal Crónica/tratamiento farmacológico, Insuficiencia Renal Crónica/diagnóstico, Tasa de Filtración Glomerular, Creatinina/análisis, Albúmina Sérica/análisis, Control Glucémico, Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico, Inhibidores del Cotransportador de Sodio-Glucosa 2/uso terapéutico, Anemia/terapia

Texto completo

Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence

Rossing, Peter; Caramori, Luiza M; Chan, Juliana C. N; Earley, Amy; de Boer, Ian H.

Kidney int; 102 (5), 2022

The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of the KDIGO 2020 guideline on the topic. The guideline targets a broad audience of clinicians treating people with diabetes and CKD. ...

Insuficiencia Renal Crónica/tratamiento farmacológico, Diabetes Mellitus Tipo 2/prevención & control, Automanejo, Control Glucémico, Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico, Antagonistas de Receptores de Angiotensina/uso terapéutico, Inhibidores del Cotransportador de Sodio-Glucosa 2/uso terapéutico

Texto completo

Guías de práctica clínicas prevención secundaria de la enfermedad renal crónica

Chile. Ministerio de Salud. Gobierno de Chile.

Entregar recomendaciones para apoyar a los equipos de salud en la toma de decisiones respecto al diagnóstico, tratamiento y derivación de las personas con ERC....

Insuficiencia Renal Crónica/prevención & control, Insuficiencia Renal Crónica/diagnóstico, Insuficiencia Renal Crónica/tratamiento farmacológico, Tasa de Filtración Glomerular, Proteinuria/orina, Albuminuria/orina, Antivirales/uso terapéutico, Antibacterianos/uso terapéutico, Hipolipemiantes/uso terapéutico, Insulina/uso terapéutico

Texto completo

Chronic kidney disease in adults: assessment and management

England. National Institute for Health and Care Excellence.

This guideline covers the care and treatment of people with, or at risk of developing, chronic kidney disease. It aims to prevent or delay the progression of chronic kidney disease, reduce or prevent the development of complications, and reduce the risk of cardiovascular disease....

Insuficiencia Renal Crónica/diagnóstico, Insuficiencia Renal Crónica/prevención & control, Insuficiencia Renal Crónica/tratamiento farmacológico, Antihipertensivos/uso terapéutico, Sistema Renina-Angiotensina, Inhibidores de Agregación Plaquetaria/uso terapéutico, Anticoagulantes/uso terapéutico

Texto completo

Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the American College of Physicians

Qaseem, A; Hopkins, RH Jr; Sweet, D. E; Starkey, M; Shekelle, P.

Ann. intern. med; 159 (12), 2013

DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. METHODS: This guideline is based on a systematic evidence review eval...

Insuficiencia Renal Crónica/diagnóstico, Insuficiencia Renal Crónica/tratamiento farmacológico, Progresión de la Enfermedad, Triaje, Antagonistas de Receptores de Angiotensina/uso terapéutico, Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico, Antihipertensivos/uso terapéutico, Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico, Hipolipemiantes/uso terapéutico, Gemfibrozilo/uso terapéutico, Enfermedades Asintomáticas, Quimioterapia Combinada, Enfoque GRADE

Texto completo